Form 4: Director Robert Bessler Sells LifeStance Health Stock

Director Robert Bessler reported a sale of LifeStance Health Group, Inc. common stock totaling 5,100 shares for approximately $35,700.

Summary

• Director Robert Bessler executed a transaction involving the sale of LifeStance Health Group, Inc. common stock.
• A total of 5,100 shares were sold on April 21, 2026, at a weighted average price of $7.01 per share.
• The total value of the transaction was approximately $35,700.
• Following these transactions, Bessler beneficially owns 1,309,397 shares indirectly through Vitthal LLC and 1,426,196 shares indirectly through Shama LLC.
• Additionally, 57,619 shares are held directly, and 36,363 shares are held indirectly through Alpine Glow Capital, where Bessler is the manager and sole member.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the director's sale of shares, which can be perceived as a bearish signal by the market.

Negatives

• Director Robert Bessler sold a significant number of shares, indicating a potential reduction in his direct stake or confidence in the short-term stock performance.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by directors, can sometimes be interpreted by the market as a signal of reduced confidence, though it can also be for personal financial planning or diversification purposes. The context of the overall market and company performance is crucial for a complete assessment.

Stakeholder Impact

• Shareholders may view the director's sale as a potential negative signal, possibly impacting short-term stock sentiment.

Key Dates

Recommendation

The filing reports an insider sale, which warrants attention but does not provide sufficient information on the company's overall financial health or future prospects to warrant a strong buy or sell recommendation. A 'hold' position allows for further monitoring of the company's performance and any subsequent insider trading activity.

Keywords

LifeStance Health Group, LFST, Form 4, Insider Trading, Stock Sale, Director Transaction, Beneficial Ownership